Recent Headlines
Within Biotechnology
Creative Diagnostics Announces Product Promotion for Antigens Towards the Worldwide Market
Creative Diagnostics - Quality monoclonal and polyclonal antibody provider for the global market at very substantial savings begins at this thanksgiving month. - November 19, 2014 - Creative Diagnostics
Experimentica Ltd Announces a Strategic Partnership with the Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland
Experimentica Ltd., a Finland-based ophthalmic CRO, announces a strategic partnership with The Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland. SILK is a research network composed of research units engaged in basic and clinical eye and vision research. Dr. Giedrius... - November 19, 2014 - Experimentica Ltd
Creative Bioarray’s High Quality Dry Bath Incubators
Creative Bioarray is a well-recognized biotech company. The company is specializing in providing bio-laboratory products and services such as human tissue, animal tissue, tissue array, microorganisms, cells, probes, cell services, biosample services, histology services, and also laboratory equipments. - November 16, 2014 - Creative Bioarray
Jake Worthington to Perform at Starry Night Houston
Houston native Jake Worthington, a recent finalist on The Voice, will perform at Starry Night Houston on Saturday, Nov. 15 at Discovery Green. The Pediatric Brain Tumor Foundation’s Starry Night 8.5K is an evening walk/run that shines a light on kids battling one of the deadliest forms of... - November 15, 2014 - Pediatric Brain Tumor Foundation
Atlanta, San Francisco Top $100,000 for Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, attracted 875 participants in Atlanta and San Francisco on Nov. 8. At start time, the events had raised $116,000. The crowds came to the 8.5K events at Centennial Olympic Park... - November 15, 2014 - Pediatric Brain Tumor Foundation
MoBiTec GmbH, Germany, Offers New Bacillus Megaterium Strain for Gene Expression and Protein Production - YYBm1
MoBiTec GmbH expands its product line of tools for gene expression in Bacillus megaterium with the new expression host YYBm1. Strain YYBm1 is unable to utilize the expression system's inductor molecule xylose as carbon source. - November 13, 2014 - MoBiTec GmbH
MoBiTec GmbH's Supplier Peninsula Laboratories, USA, with New Corporate Website
Peninsula Laboratories International, Inc, USA, a leading supplier of superior immunology products, proudly announces its own corporate website www.penlabs.com. Formerly, PenLabs was integral part of Bachem's internet presence. - November 11, 2014 - MoBiTec GmbH
Creative Bioarray’s WISP-PTC Dry Bath Incubator
Creative Bioarray launches another brand new dry bath incubator: WISP-PTC Dry Bath Incubator, with the support of its advanced technology platform. - November 08, 2014 - Creative Bioarray
Colorado BioScience Association Showcases Industry’s Best at 2014 Awards Dinner Celebration
Centennial’s AlloSource is the 2014 BioScience Company of the Year, Boulder’s Virocyt is the industry’s Rising Star and Dr. Richard Duke is honored with CBSA’s Lifetime Achievement Award. - November 06, 2014 - Colorado BioScience Association
Creative Bioarray’s 3-in-I Mini Dry Bath Incubator
Creative Bioarray launches its 3-in-1 multifunctional Mini Dry Bath Incubator - WISP-TR Dry Bath Incubator. - November 06, 2014 - Creative Bioarray
Enzyme Activity Assay Service Are Available in Creative Biomart
Creative Biomart, a world leading supplier of recombinant proteins, antibodies, enzymes and other biotech services for the research community in the field of biology, has announced today for its official release of the novel service-- Enzyme activity assay. This assay is in the aim of assisting... - November 06, 2014 - Creative Biomart
VMRD’s Q Fever FA Substrate Slide Now Available
VMRD announced today the availability of a substrate slide that can be used for the detection of antibody to Coxiella burnetii (Q fever). The slide can detect antibody to phases I & II of Q fever. - November 05, 2014 - VMRD, Inc.
ABR Launches New Mycoplasma Testing Services
ABR (now a VMRD division) announced today the availability of new testing services that can detect the presence of mycoplasma in animal origin products, master virus seeds, and other sample types. The new services satisfy various regulatory standards including US Pharmacopoeia (USP), European... - November 04, 2014 - VMRD, Inc.
Pathology Diagnostics Ltd Publish First White Paper in Series - The Use of Immunohistochemistry in Biomarker Research and Clinical Trials
The white paper, "The Use of Immunohistochemistry in Biomarker Research and Clinical Trials" is to be the first of a series of white papers published by Pathology Diagnostics over the next six months. - November 04, 2014 - Pathology Diagnostics Ltd
Pipette.com Alleviates Lab Budget Cuts with BrandTech’s Plate and Multichannel Pipette Promotion
Pipette.com offers the Buy 1 BrandTech Transferpette S Multichannel Pipette and Get 1 Case of BRANDplates for Free. This promotion will benefit those seeking to replenish their plate inventory. - November 01, 2014 - Pipette.com
NanoHybrids Receives Funding to Develop Molecular Imaging Agent for Atherosclerosis
NanoHybrids, Inc., an Austin-based, emerging biotech company developing nanotechnology-based clinical and pre-clinical solutions, was recently awarded a Small Business Innovation Research (SBIR) contract grant to develop a targeted biocompatible imaging contrast agent that will help detect high risk atherosclerotic plaques. - October 25, 2014 - NanoHybrids
Trial Reported in Headache and Pain Journal Further Confirms the Effectiveness of electroCore’s Non-Invasive Vagus Nerve Stimulation Treatment for Headache
Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore’s hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4%... - October 25, 2014 - electroCore
Liftstream Report Finds Ten Men for Every Woman Present in Biotech Boardrooms
Liftstream Ltd, a company providing executive recruitment services to the biotechnology sector, announces the publication of its new gender diversity report, “Diversifying the Outlook – The X&Y of Biotechnology Leadership,” a detailed analysis of women leaders in European and US life biotech companies. The research covers 700 companies, 60 C-level interviews and 530 survey respondents. - October 25, 2014 - Liftstream
Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing
Pipette.com has added the Sartorius CPA Semi-Micro Balance to their portfolio. This introductory price is only for a limited time and will benefit lab technicians looking for a dependable and durable laboratory balance. - October 24, 2014 - Pipette.com
Amoy Diagnostics, China, Expands List of CE-Marked Real-Time PCR Kits for Cancer Diagnostics
Amoy Diagnostics, who recently appointed MoBiTec GmbH as distributor for Germany, proudly announces the availability of further CE-marked detection kits, which are based on a proprietary real-time PCR technology called “ADx-ARMS,” for Cancer Diagnostics. - October 24, 2014 - MoBiTec GmbH
Boston, Philadelphia Join Starry Night to Cure the Kids
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, attracted more than 500 participants in Boston and Philadelphia on Oct. 18. At start time, the events had raised $61,000. The crowds came to the 8.5K events at Joe Moakley... - October 23, 2014 - Pediatric Brain Tumor Foundation
Colorado BioScience Association Announces Finalists for 2014 "Company of the Year" and "Rising Star" of the Year Awards
The Colorado BioScience Association (CBSA) has chosen the finalists for the 2014 “Company of the Year” and “Rising Star” Awards, which they will present during the Annual Awards Dinner held on Thursday, November 6, at the Marriott City Center, 1701 California Street, Denver,... - October 22, 2014 - Colorado BioScience Association
Colorado BioScience Association Honors Industry’s Best at 2014 Awards Dinner, Featuring Keynote by Olympic Medalist & Parkinson’s Survivor Davis Phinney
The Colorado BioScience Association (CBSA) will honor outstanding bioscience companies and individuals throughout the state at its Annual Awards Dinner, November 6, at the Denver Marriott City Center. This year’s event will feature keynote speaker Davis Phinney, Olympic medalist and cycling great who is successfully living with early-onset Parkinson’s disease and in 2004 founded the Colorado-based Davis Phinney Foundation. - October 20, 2014 - Colorado BioScience Association
MoBiTec, Germany, and Amoy Diagnostics, China, Sign Distribution Agreement for the German Market
MoBiTec GmbH, Germany, focused on selling products for life science and IVD research, has entered into a distribution agreement with Amoy Diagnostics, China. Together with AmoyDx, MoBiTec will continue to expand its portfolio of premier brands. - October 19, 2014 - MoBiTec GmbH
Creative Diagnostics Releases the Hot Products of October for Monoclonal Antibodies
Creative Diagnostics announced the release of its hot products of Oct. 2014 for monoclonal antibodies. - October 17, 2014 - Creative Diagnostics
OutsourcePharma Advisory Board CRO Reviews Database Surpasses Growth Milestone
Online community of outsourcing decision makers doubles its CRO reviews database - October 15, 2014 - Life Science Strategy Group, LLC
Bioo Scientific Offers Complete Line of Sensitive ELISAs for Quinolone Residue Detection
Bioo Scientific now offers the broadest range of commercial kits for quinolone residue detection, with the launch of several new ELISAs. The AuroFlow™ Fluoroquinolone Strip Test Kit for Meat, the AuroFlow™ Fluoroquinolone Strip Test Kit for Milk and the MaxSignal® Fluoroquinolone ELISA Test Kit are rapid qualitative lateral flow assays for the detection of a broad range of flouroquinolone residues. - October 15, 2014 - Bioo Scientific
Zenascope Aids in the Screening and Detection of Cervical Cancer in Developing Countries
Zenalux Biomedical, Inc. presented its latest findings on the investigational use of the Zenascope® in cervical cancer screening at the U.S. Investigators’ Symposium on Global Non-Communicable Disease Research. The poster—titled “Towards a viable solution for a see and treat paradigm for cervical pre-cancer screening in East Africa”—focused on the use of the Zenascope in cervical pre-cancer screening in East Africa where neither HPV testing nor Pap smears are routinely available. - October 10, 2014 - Zenalux Biomedical, Inc.
Creative Biomart Newly Introduced It’s Fc Fusion Protein Production Service
Creative Biomart, a word leading Biotech Company had newly released its novel service of Fc Fusion Protein Production Service in the aim of providing more choices for the scientists conducting biomedical and immunology research. The potential clinical application of cytokins to modulate immune... - October 10, 2014 - Creative Biomart
Starry Night Chicago Raises Funds to Help Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on childhood brain tumors, made its debut in Chicago on Oct. 4 with the support of more than 500 participants. At start time, the event had raised $46,000. The crowd came to the 8.5K at Arlington... - October 09, 2014 - Pediatric Brain Tumor Foundation
Green Biologics is Named in the 2014 Global Cleantech 100
List Recognises the Top Private Companies in Clean Technology - October 08, 2014 - Green Biologics Ltd
AveXis Announces the Completion of Dosing of the Low Dose Cohort in US Clinical Trial for Spinal Muscular Atrophy
AveXis, Inc., a clinic-stage gene therapy company, today announced the completion of dosing in the low dose cohort in the world's first human gene therapy trial for the treatment of infants with spinal muscular atrophy (SMA). The trial (NCT02122952) opened for enrollment in April... - October 08, 2014 - AveXis Inc.
Colorado BioScience Association Promotes Colorado’s Medical Technology Industry, Along with Two of the State’s Economic Development Entities at AdvaMed 2014
Representatives from the Colorado BioScience Association, the Colorado Springs Regional Business Alliance and the Metro Denver Economic Development Corporation will tout Colorado’s growing medical device and diagnostic sectors during the '2014 AdvaMed: The MedTech Conference' in Chicago, IL, October 6-8. - October 08, 2014 - Colorado BioScience Association
Colorado Institute for Drug, Device and Diagnostic Development Awards Funding & Management Assistance to Sapphire Technology
The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has selected Denver-based Sapphire Technology, LLC, to receive funding and management assistance. - October 07, 2014 - Colorado Institute for Drug, Device and Diagnostic Development
AveXis Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for chariSMA for the Treatment of Spinal Muscular Atrophy
AveXis Inc., a synthetic biology platform company primarily focused on developing treatments for Spinal Muscular Atrophy (SMA) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its product scAAV9, called chariSMA to treat Spinal Muscular Atrophy... - October 04, 2014 - AveXis Inc.
Ability of Semiconductor DNA Sequencing to Transform Healthcare and Save Lives Recognised by the 2014 Faraday Medal to Professor Chris Toumazou
DNA Electronics (‘DNAe’), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for sepsis, announces today that its founder, Chairman and CEO Professor Chris Toumazou FRS, FREng, FMEDSci, FIET, FIEEE, FCGI, FRSM has been... - October 04, 2014 - DNA Electronics
MoBiTec GmbH: PDE Inhibitors Show Sonic Effects on Prostate Cancer
In 2009, Phosphodiesterase 4D (PDE4D) was identified as a novel proliferation-promoting factor in prostate cancer. Now, the effects of two selective PDE4D inhibitors, NVP-ABE171 and cilomilast, as anti-prostate cancer therapies were examined. - October 02, 2014 - MoBiTec GmbH
Bide Pharmatech Cooperates with 2 New Distributors in India and France
Bide Pharmatech, a leading pharmaceutical intermediate provider, has announced the signature of a new agreement with two distributors: Interchim in France and Prince Scientific & Surgicals in India. - September 30, 2014 - Bide Pharmatech Ltd.
GenapSys Announces Key Hire to Senior Management Team
Addition of Vice President Strengthens Application and Product Development of the GENIUS(tm) 110 DNA Sequencing system. - September 25, 2014 - Genapsys Inc.
Randomized Data Presented at International Headache Meeting (EHMTIC)) Shows Gammacore Significantly Reduces Cluster Headache Attack Frequency*
The biannual European Headache and Migraine Trust International Conference (EHMTIC) meeting concluded yesterday in Copenhagen, where more than 900 neurologists and other headache specialists came to hear about the latest advances in managing severe headache conditions, including electroCore’s... - September 25, 2014 - electroCore
New Osteology Book on Clinical Research - Get Your Copy at the EAO in Rome
At the EAO congress in Rome, the Osteology Foundation will present its second book of the series “Osteology Guidelines for Oral & Maxillofacial Regeneration.” The book from the editors William V. Giannobile, Niklaus P. Lang and Maurizio S. Tonetti focuses on Clinical Research, and will be available fresh from the press during the congress. - September 25, 2014 - Osteology Foundation
DNAe Completes Its Leadership Team with Key Operational and R&D Appointments as It Takes Forward Its DNA Diagnostic Test for Sepsis
DNA Electronics ("DNAe"), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for sepsis, today announced the completion of its leadership team with the appointment of Kevin Stearn as Operational Director, and Dr David Edington as Vice President, R&D. - September 24, 2014 - DNA Electronics
Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership
Clinical Network Services (CNS) an integrated service consultancy focused on product development and Ventac Partners, a life science consulting firm, today announced that they have signed a cooperative partnership agreement to provide joint service offerings in the biotech and pharma sectors in fundraising, company evolution and drug development. The partnership pools the corporate expertise of Ventac Partners with the regulatory expertise of CNS and expands the geographical reach of both. - September 22, 2014 - Ventac Partners
Signed Robin Williams Skate Deck Part of Auction to Benefit PBTF
Actor and comedian Robin Williams was well-known for his philanthropy, especially for children’s causes. Just a few months before his death, he signed a skateboard to be included in an auction to help children with brain tumors. Williams worked with the skate deck’s artist, Cody Gallo,... - September 21, 2014 - Pediatric Brain Tumor Foundation
Primerdesign Open for £3000 Sponsored Student Scheme
Every year Primerdesign sponsors a number of postgraduate students across the UK. The sponsorship helps with their research by actively promoting good science and providing some free training and high quality real-time PCR kits and reagents. Projects are assessed and a number of sponsorships... - September 21, 2014 - Primerdesign Ltd
Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes
Pipette.com offers new promotions on micropipettes from major brands Sartorius/Biohit, Socorex, Capp, and AccuPet. The promotion is designed to help labs find the right pipette for their work and keep them within their budget. - September 20, 2014 - Pipette.com
Four Colorado Bioscience Companies Presented at the Inaugural White Hat Life Science Investor Conference in Phoenix
Four Colorado companies were selected to present at the 2014 "White Hat Life Science Investor Conference," in Phoenix, AZ. The Colorado companies included among the 34 presenting companies from across the region, were: EndoShape, Fluonic, ValveXchange and ViroCyt. - September 19, 2014 - Colorado BioScience Association
Newsletter XVII is Available from MoBiTec GmbH, Germany
MoBiTec's periodical Newsletter, issued several times a year, informs about new, exciting products in the categoríes vector systems and gene expression, genomics, proteomics, fluorescence applications, cell biology, labware, and more. - September 19, 2014 - MoBiTec GmbH
Creative Biomart Morning Talk for Mutagenesis Services
Creative BioMart, a world leading Biotech Company, has conducted a morning talk to discuss its mutagenesis. This talk lasted for nearly one hour. Mutagenesis is a fundamentally important DNA manipulation technique. It involves changing the base sequence of the DNA molecule, usually for the... - September 18, 2014 - Creative Biomart
Pathology Diagnostics Ltd (PDL) Works Hand in Hand with Grants4Growth
Pathology Diagnostics Ltd is a highly successful SME which has recently expanded its facilities by moving to Stirling House business centre to a bespoke state-of-the-art pathology laboratory five times larger than its previous premises. As part of the company investment in the new facility, senior... - September 14, 2014 - Pathology Diagnostics Ltd